AMC 083 / UPCC 12716: Tissue Acquisition for Analysis of Prognostic Factors Immunology and Genetic Progression of HIV-1 Associated Malignancies
Recruiting
18 years - 99 years
All
Phase
N/A
5 participants needed
1 Location
Brief description of study
The main purpose of this study is to collect tissue from people diagnosed with HIV-associated cancer. We will use these samples to look for genetic changes associated with HIV- and other virus-related cancers.
This may lead to better ways of preventing, detecting, and treating HIV-associated cancers.
Detailed description of study
If you agree to take part in this study, you will give a blood sample and a tumor tissue sample.
We will collect the sample(s) at the same time we draw blood for routine medical treatment. We will collect a small piece of your tumor tissue when we take a biopsy for your medical treatment.
If there is extra tissue from an earlier biopsy that we can use for this study, we will use a small piece of that tissue.
Giving tumor tissue for this research will not add to your surgery time or add any extra procedures. We will send your tissue back if your doctors need it to run more tests for your medical treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: N/A
-
Age: 18 years - 99 years
-
Gender: All
1. Participants must have a diagnosis of HIV- associated malignancy of one of three types:
- Diffuse Large B Cell Lymphoma
- Non-Small Cell Lung Malignancy
- Cervical Cancer
2. Participants must have a diagnosis of HIV.
3. Participants must be ≥ 18 years old.
Updated on
19 Feb 2024.
Study ID: 826062
